Wave Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month price objective […]